Literature DB >> 31314605

A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease.

Sean Cleymaet1, Katsuko Nagayoshi2, Edward Gettings1, Justin Faden2.   

Abstract

Introduction: This paper reviews the presenting signs and symptoms of Wilson's disease, with an emphasis on the recognition and treatment of neuropsychiatric symptoms. Areas covered: A literature search was conducted using PubMed.gov utilizing the following keywords: Wilson disease, neuropsychiatric, psychiatric symptoms, treatment, antipsychotics, mood stabilizer, psychotherapy, antidepressant, ATP7B. The diagnosis of Wilson's disease and the treatment of hepatic and neuropsychiatric symptoms are reviewed. Expert opinion: Wilson's disease is a rare autosomal recessive disorder with a heterogeneous presentation. Prominent neuropsychiatric symptoms can cloud the initial diagnosis, delaying treatment. Early disease recognition and prompt treatment to restore copper balance is critical in mitigating neuropsychiatric symptoms. Lifetime adherence to maintenance treatment with a chelating agent or zinc is vital for prevention or recurrence of symptoms. Education and supportive psychotherapy have been shown to improve medication adherence. If a psychotropic medication is needed, preference should be given to one with a low risk for extrapyramidal symptoms and hepatotoxicity.

Entities:  

Keywords:  ATP7B; Wilson disease; chelation; copper; dyskinesia; movement disorders; neuropsychiatric; psychotropic medications

Year:  2019        PMID: 31314605     DOI: 10.1080/14737175.2019.1645009

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

1.  Emerging neurological symptoms after liver transplantation: A 6-year follow-up of an adolescent patient with Wilson's disease.

Authors:  Wan-Qing Xu; Rou-Min Wang; Yi Dong; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2022-01-07       Impact factor: 5.243

2.  Molecular analysis of 53 Chinese families with Wilson's disease: Six novel mutations identified.

Authors:  Zhongyan Xiao; Yuan Yang; Hui Huang; Haiyan Tang; Liqun Liu; Jianguang Tang; Xiaoliu Shi
Journal:  Mol Genet Genomic Med       Date:  2021-07-29       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.